Lawyers and Settlements
Home Page >> Legal News Articles >> Drugs/Medical

Legal News Articles - Drugs/Medical

Zofran Judge Favors Plaintiffs, Denies GSK Motion to Dismiss

Zofran Judge Favors Plaintiffs, Denies GSK Motion to Dismiss February 9, 2016. By Jane Mundy.
Springfield, MA: GlaxoSmithKline (GSK) in December argued last December that all the federal Zofran lawsuits be dismissed, but the federal judge sided with more than 200 families who claimed that GSK failed to warn that the anti-nausea drug causes birth defects.
Read [ Zofran Judge Favors Plaintiffs, Denies GSK Motion to Dismiss ]

Officials Ask How FDA Was So Wrong on Risks of Power Morcellation

Officials Ask How FDA Was So Wrong on Risks of Power Morcellation February 8, 2016. By Heidi Turner.
Washington, DC: With 34 power morcellator lawsuits filed against Ethicon consolidated for pretrial proceedings and the US government investigating allegations against the makers of power morcellators, 2016 could be a bad year for power morcellation device makers. The devices, used in laparoscopic hysterectomy or myomectomy, have come under scrutiny due to concerns that they could inadvertently spread cancerous tissue throughout a patient’s abdomen, increasing the risk of death.
Read [ Officials Ask How FDA Was So Wrong on Risks of Power Morcellation ]

Voluntary Recall of Olympus Duodenoscope Announced While Regulators Slam Device Makers

Voluntary Recall of Olympus Duodenoscope Announced While Regulators Slam Device Makers February 7, 2016. By Heidi Turner.
Washington, DC: Olympus Corp. has announced a voluntary recall of its duodenoscope, which has been linked to serious infections in patients who underwent procedures using the device. Endoscopes and other medical devices have come under fire recently for increasingly complex designs that make proper sterilization of the devices almost impossible. In the case of the Olympic duodenoscope, reports indicate that Olympus will redesign a portion of the device to make it easier to disinfect.
Read [ Voluntary Recall of Olympus Duodenoscope Announced While Regulators Slam Device Makers ]

Rolling the Dice with Abilify

Rolling the Dice with Abilify February 6, 2016. By Gordon Gibb.
Hackensack, NJ: Most consumers conversant with adverse reaction reports associated with pharmaceutical drugs are nonetheless surprised upon learning of a particular aspect of Abilify side effects that allegedly can leave an Abilify patient in financial ruin.
Read [ Rolling the Dice with Abilify ]

Yasmin Death and “Lucky to Be Alive”

Yasmin Death and “Lucky to Be Alive” February 5, 2016. By Jane Mundy.
Hong Kong: While the FDA has been criticized for its lack of warning and other issues regarding Yasmin and Yaz, the agency is commendable compared to the Hong Kong Health Department. A Hong Kong man recently filed a lawsuit against Bayer claiming the oral contraceptive caused the death of his wife.
Read [ Yasmin Death and “Lucky to Be Alive” ]

Testosterone Side Effects: Centralization for Some Lawsuits Hinges on Ruling

Testosterone Side Effects: Centralization for Some Lawsuits Hinges on Ruling February 3, 2016. By Gordon Gibb.
Chicago, IL: A request by plaintiffs to review a ruling in late 2015 fell below the radar, but nonetheless speaks to allegations of potential health issues related to Testosterone side effects and alleged efforts by manufacturers to spin a natural aspect of aging in healthy men into a disease for the purposes of selling testosterone supplements.
Read [ Testosterone Side Effects: Centralization for Some Lawsuits Hinges on Ruling ]

US Supreme Court Won’t Hear Risperdal Appeal

US Supreme Court Won’t Hear Risperdal Appeal January 29, 2016. By Heidi Turner.
Washington, DC: The United States Supreme Court has decided it will not hear Johnson & Johnson’s appeal of a $124 million judgment against it in a Risperdal lawsuit. The lawsuit was filed by the state of South Carolina, alleging Johnson & Johnson subsidiary Ortho-McNeil-Janssen Pharmaceuticals illegally marketed its antipsychotic medication.
Read [ US Supreme Court Won’t Hear Risperdal Appeal ]

Missouri Bard G2 IVC Filter Lawsuit Alleges Defective Design, Lack of Testing

Missouri Bard G2 IVC Filter Lawsuit Alleges Defective Design, Lack of Testing January 28, 2016. By Gordon Gibb.
St. Louis, MO: The consolidation and centralization of Bard IVC Filter lawsuits in Arizona (In re Bard IVC Filters Products Liability Litigation MDL No. 2641, JPML August 17, 2015) is indicative of the interest and significance of a legal issue that appears to be poised for further growth amidst the aging American population. With baby boomers advancing into retirement and medical issues such as blood clots continuing to gain a foothold in the greater societal health paradigm, allegedly inferior products aimed at preventing blood clots from fostering serious health issues are themselves the source of grievous concern and related litigation.
Read [ Missouri Bard G2 IVC Filter Lawsuit Alleges Defective Design, Lack of Testing ]

New Year Sees 400 More Lawsuits Added to Xarelto MDL

New Year Sees 400 More Lawsuits Added to Xarelto MDL January 28, 2016. By Heidi Turner.
New Orleans, LA: The new year has seen more than 400 Xarelto lawsuits added to the multidistrict litigation, with almost 3,000 lawsuits now consolidated for pretrial proceedings. Xarelto lawsuits allege patients given the blood thinner were not properly warned about the increased risk of bleeding events, nor that the newer-generation anticoagulant did not have an approved antidote.
Read [ New Year Sees 400 More Lawsuits Added to Xarelto MDL ]

Judge Denies GlaxoSmithKline Motion to Dismiss Lawsuits

Judge Denies GlaxoSmithKline Motion to Dismiss Lawsuits January 27, 2016. By Heidi Turner.
New York, NY: A judge has reportedly denied GlaxoSmithKline’s motion to dismiss Zofran lawsuits, which alleged the morning sickness drug caused birth defects in infants exposed to the medication prior to birth. Plaintiffs in the Zofran side effects lawsuits argued it’s too early to dismiss the lawsuits because no discovery has happened yet, and because animal studies suggest a link between Zofran and birth defects.
Read [ Judge Denies GlaxoSmithKline Motion to Dismiss Lawsuits ]

Page: 1  2  3  4  5  6  7  8  9  -  10»  -  100»  -  110   Next»

Request Legal Help

First name:

Last name:

Email address:

Phone number(s):

Zip/Postal Code:

Defendant:
Describe your complaint:

Category:
By submitting this form I agree to the Terms of Service.
There is no cost to submit this form.
I would like to be interviewed by a journalist.
Subscribe to our free weekly newsletter.

Check Claim Status Advertise with us Legal Funding


Legal News

Legal Services:

Facebook



 
FAQ | TOS | Privacy | Disclaimer | About Us | Contact Us | Press | Advertise | Member Login | Site Map | View Mobile Website

American Bar Association - Proud Member   Better Business Bureau   CAALA   Best of the Web Approved   Public Justice


This work is licensed under a Creative Commons Attribution-NoDerivs 3.0 Unported License © 2001-2016 Online Legal Media. All rights reserved.


Visit other Online Legal Media Websites:

BigClassAction.comCALaborLawNews.com
OnlineLegalMarketing.comHealthEffectsOfAsbestos.com
Get Legal Help